788 related articles for article (PubMed ID: 18487007)
61. [Synchronous bilateral renal adenocarcinoma. Our experience with conservative kidney surgery].
Pérez García FJ; Regadera Sejas FJ; Rodríguez Martínez JJ; Martínez Gómez FJ; Casasola Chamorro J; Sánchez Trilla A
Arch Esp Urol; 1999 Jun; 52(5):471-7. PubMed ID: 10427885
[TBL] [Abstract][Full Text] [Related]
62. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
[TBL] [Abstract][Full Text] [Related]
63. Outcome of renal tumors in young adults.
Siemer S; Hack M; Lehmann J; Becker F; Stöckle M
J Urol; 2006 Apr; 175(4):1240-3; discussion 1243-4. PubMed ID: 16515969
[TBL] [Abstract][Full Text] [Related]
64. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma.
Parker A; Lohse C; Cheville J; Leibovich B; Igel T; Blute M
Int J Urol; 2008 Apr; 15(4):304-8. PubMed ID: 18380816
[TBL] [Abstract][Full Text] [Related]
65. Bilateral breast cancer: differential diagnosis using histological and biological parameters.
Gong SJ; Rha SY; Jeung HC; Roh JK; Yang WI; Chung HC
Jpn J Clin Oncol; 2007 Jul; 37(7):487-92. PubMed ID: 17673471
[TBL] [Abstract][Full Text] [Related]
66. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
[TBL] [Abstract][Full Text] [Related]
67. TNM stage is the most important determinant of survival in metachronous lung cancer.
Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
[TBL] [Abstract][Full Text] [Related]
68. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract][Full Text] [Related]
69. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
[TBL] [Abstract][Full Text] [Related]
70. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
[TBL] [Abstract][Full Text] [Related]
71. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.
Jeon HG; Lee SR; Kim KH; Oh YT; Cho NH; Rha KH; Yang SC; Han WK
Urology; 2010 Sep; 76(3):574-9. PubMed ID: 20303148
[TBL] [Abstract][Full Text] [Related]
72. [Sporadic bilateral kidney tumour: practical approach and place of conservative surgery].
Hintzy MC; Hupertan V; Larousserie F; Chretien Y; Thiounn N; Dufour B; Mejean A
Prog Urol; 2006 Apr; 16(2):134-8. PubMed ID: 16734233
[TBL] [Abstract][Full Text] [Related]
73. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome.
Holmäng S; Johansson SL
Cancer; 2004 Aug; 101(4):741-7. PubMed ID: 15305404
[TBL] [Abstract][Full Text] [Related]
74. [Impact of diagnosis and treatment of early stage secondary tumors on outcome for the oncologic ORL patient].
Grosjean P; Monnier P
Schweiz Med Wochenschr Suppl; 2000; 116():43S-46S. PubMed ID: 10780070
[TBL] [Abstract][Full Text] [Related]
75. Multiple lung cancers prognosis: what about histology?
Riquet M; Cazes A; Pfeuty K; Ngabou UD; Foucault C; Dujon A; Banu E
Ann Thorac Surg; 2008 Sep; 86(3):921-6. PubMed ID: 18721583
[TBL] [Abstract][Full Text] [Related]
76. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma.
Ficarra V; Martignoni G; Lohse C; Novara G; Pea M; Cavalleri S; Artibani W
J Urol; 2006 Apr; 175(4):1235-9. PubMed ID: 16515968
[TBL] [Abstract][Full Text] [Related]
77. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
78. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
[TBL] [Abstract][Full Text] [Related]
79. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
80. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan.
Huang PC; Huang CY; Huang SW; Lai MK; Yu HJ; Chen J; Pu YS
Int J Urol; 2006 Jul; 13(7):864-9. PubMed ID: 16882044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
